In the media September 16, 2022
Policy change by Cigna to now begin covering Deep TMS for the treatment of obsessive-compulsive disorder,...
In the media August 26, 2022
Story featuring insights from four CEOs (including BrainsWay’s CEO, Dr. Christopher von Jako) about...
In the media August 22, 2022
Patient Lori Jackson details her history of depression, her unsuccessful treatments with medication,...
In the media June 20, 2022
Deep TMS patient Gabe Hogan details his backstory on living with depression and how he found relief using...
In the media May 23, 2022
News segment centering around local patient Thomas Hartzell’s treatment-resistant depression and...
In the media May 17, 2022
Live the Sun Valley Experience Mental Health Fair held by Sun Valley Medical Center and Sun Valley Research...
In the media March 25, 2022
Detailing Deep TMS as a notable and effective approach for individuals living with medication-resistant...
In the media January 18, 2022
8-minute video interview with BrainsWay President and CEO, Christopher von Jako providing expertise around...
In the media January 13, 2022
Dr. Aron Tendler, MD, board-certified psychiatrist and Chief Medical Officer of BrainsWay, shares insights...
In the media December 22, 2021
Proof-of-concept research on Deep TMS as a treatment for alcohol dependence, with commentary from Dr....
In the media December 1, 2021
A behind the curtains look at Deep TMS treatment and how it is currently providing relief for a local...
In the media October 26, 2021
The importance of mental health is highlighted, with statements from BrainsWay and Chief Medical Officer...
In the media September 20, 2021
Patient testimonials, smoker statistics, and discussion around BrainsWay’s Deep TMS smoking addiction...
In the media September 20, 2021
Highlighting the recent FDA clearance for anxious depression with references to the study and a quote...
In the media September 9, 2021
Dr. Tendler discusses how emerging technologies, such as BrainsWay’s Deep TMS™, offer hope to...
In the media September 7, 2021
BrainsWay CEO and President, Christopher von Jako, PhD discusses the navigation, education, and partner...
In the media August 25, 2021
Summary of the release and research lending to the FDA-clearance of anxious depression, with quotes from...
In the media August 20, 2021
Summary of the release, highlighting how this FDA clearance will allow BrainsWay to increase patient...
